RP — Replicel Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Replicel Life Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.053	0.052	0.238	0.43	0.076
Net Total Accounts Receivable
Net Total Receivables	0.052	0.064	0.061	0.082	0.038
Prepaid Expenses
Total Current Assets	0.233	0.186	0.393	0.636	0.162
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.006	0.004	0.003	0.002	0.001
Long Term Notes Receivable
Total Assets	0.505	0.421	0.592	0.798	0.288
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.27	2.24	1.67	2.07	1.82
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.93	5.48	7.43	6.71	4.82
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-4.43	-5.06	-6.84	-5.92	-4.53
Total Liabilities & Shareholders' Equity	0.505	0.421	0.592	0.798	0.288
Total Common Shares Outstanding